Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 65 | 1 | 9 | 1 | €817.90 | €824.51 | 0.808% |
| Vertex Pharmaceuticals Inc. | 60 | 2 | 11 | 0 | €429.15 | €450.36 | 4.943% |
| Boston Scientific | 57 | 0 | 9 | 0 | €70.00 | €76.43 | 9.183% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 10 | 0 | €1,036.5 | €1,077.4 | 3.946% |
| Alnylam Pharmace. | 45 | 0 | 5 | 0 | €247.10 | €271.69 | 9.952% |
| Insmed Inc. | 43 | 0 | 5 | 0 | €63.50 | €76.19 | 19.983% |
| UnitedHealth Group Inc. | 42 | 1 | 9 | 0 | €511.70 | €547.55 | 7.005% |
| Neurocrine Bioscience | 42 | 0 | 11 | 0 | €134.85 | €149.47 | 10.843% |
| Johnson & Johnson | 41 | 1 | 7 | 0 | €147.10 | €196.23 | 33.399% |
| Tenet Healthcare | 41 | 0 | 8 | 0 | €138.00 | €144.57 | 4.760% |
| HCA Holdings Inc. | 38 | 0 | 7 | 0 | €330.60 | €336.64 | 1.826% |
| Intuitive Surgical Inc | 36 | 0 | 3 | 0 | €424.45 | €397.79 | -6.282% |
| Acadia Pharmaceuticals | 35 | 1 | 8 | 0 | €14.31 | €29.92 | 109.052% |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | €105.00 | €125.72 | 19.732% |
| Edwards Lifesciences Corp. | 33 | 1 | 9 | 0 | €59.20 | €83.82 | 41.588% |
| AbbVie Inc. | 32 | 0 | 7 | 0 | €173.94 | €180.29 | 3.650% |
| Stryker Corp. | 31 | 0 | 7 | 0 | €300.30 | €340.29 | 13.317% |
| Cytokinetics Inc. | 31 | 1 | 0 | 0 | €51.50 | €84.22 | 63.539% |
| Thermo Fisher Scientific Inc. | 31 | 1 | 5 | 1 | €545.80 | €570.62 | 4.548% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.15 | €41.49 | 58.701% |
| Intra-Cellular Therapies Inc. | 30 | 0 | 3 | 0 | €67.50 | €85.00 | 25.926% |
| Illumina Inc. | 28 | 4 | 3 | 0 | €113.04 | €161.98 | 43.294% |
| Amgen Inc. | 28 | 0 | 4 | 0 | €295.30 | €304.82 | 3.223% |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 8 | 1 | €42.62 | €56.72 | 33.087% |
| Dexcom Inc. | 25 | 0 | 9 | 0 | €63.88 | €121.92 | 90.851% |